We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-29.74%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$243M
AUM Growth
-$369M
Cap. Flow
-$216M
Cap. Flow %
-88.84%
Top 10 Hldgs %
9.9%
Holding
504
New
52
Increased
49
Reduced
307
Closed
94

Top Buys

Rank Stock Value
1
OXSQ icon
Oxford Square Capital
OXSQ
+$1.88M
2
NEM icon
Newmont
NEM
+$1.81M
3
BEP icon
Brookfield Renewable
BEP
+$1.69M
4
XRN
Chiron Real Estate Inc
XRN
+$1.68M
5
PSA icon
Public Storage
PSA
+$1.65M

Top Sells

Rank Stock Value
1
RS icon
Reliance Steel & Aluminium
RS
+$4.3M
2
VALE icon
Vale
VALE
+$4.14M
3
DEA
Easterly Government Properties
DEA
+$4.07M
4
NP
Neenah, Inc. Common Stock
NP
+$4.04M
5
ABR icon
Arbor Realty Trust
ABR
+$3.91M

Sector Composition

Rank Sector Weight
1 Financials 20.56%
2 Healthcare 19.87%
3 Real Estate 12.49%
4 Energy 9.44%
5 Materials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBX
251
DELISTED
Unity Biotechnology
UBX
$249K 0.1%
4,301
-627
-13% -$39.5K
ASMB icon
252
Assembly Biosciences
ASMB
$516M
$248K 0.1%
1,396
-204
-13% -$43.7K
MRTX
253
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$247K 0.1%
3,211
-467
-13% -$41.9K
DRNA
254
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$247K 0.1%
13,430
-1,941
-13% -$37.7K
MDGL icon
255
Madrigal Pharmaceuticals
MDGL
$11.4B
$246K 0.1%
3,683
-543
-13% -$45.2K
VYGR icon
256
Voyager Therapeutics
VYGR
$189M
$244K 0.1%
26,708
-3,900
-13% -$44.8K
BCRX icon
257
BioCryst Pharmaceuticals
BCRX
$2.35B
$242K 0.1%
121,058
-17,661
-13% -$48.6K
KURA icon
258
Kura Oncology
KURA
$826M
$242K 0.1%
24,329
-3,543
-13% -$40.6K
KRYS icon
259
Krystal Biotech
KRYS
$10.8B
$239K 0.1%
5,516
-791
-13% -$41.4K
LXRX icon
260
Lexicon Pharmaceuticals
LXRX
$1.04B
$236K 0.1%
121,070
-10,216
-8% -$30.4K
IMMU
261
DELISTED
Immunomedics Inc
IMMU
$235K 0.1%
17,397
-2,528
-13% -$42.5K
CRSP icon
262
CRISPR Therapeutics
CRSP
$4.77B
$233K 0.1%
5,497
-809
-13% -$41.8K
BHVN
263
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$233K 0.1%
6,857
-1,003
-13% -$45.9K
RYTM icon
264
Rhythm Pharmaceuticals
RYTM
$7.25B
$232K 0.1%
15,224
-2,226
-13% -$39.9K
SAGE
265
DELISTED
Sage Therapeutics
SAGE
$232K 0.1%
8,072
-681
-8% -$39.4K
MGTX icon
266
MeiraGTx Holdings
MGTX
$1.11B
$230K 0.09%
17,114
-2,482
-13% -$41.9K
QURE icon
267
uniQure
QURE
$2.93B
$230K 0.09%
4,855
-706
-13% -$40.6K
AGEN
268
Agenus
AGEN
$329M
$229K 0.09%
4,770
-696
-13% -$43.7K
RCKT icon
269
Rocket Pharmaceuticals
RCKT
$351M
$229K 0.09%
16,415
-2,391
-13% -$47.3K
DCPH
270
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$229K 0.09%
5,572
-799
-13% -$44.4K
ESPR
271
DELISTED
Esperion Therapeutics
ESPR
$228K 0.09%
7,235
-1,063
-13% -$56.1K
ORTX
272
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$219K 0.09%
2,911
-426
-13% -$49.1K
VKTX icon
273
Viking Therapeutics
VKTX
$3.84B
$212K 0.09%
45,220
-6,603
-13% -$40.6K
DTIL icon
274
Precision BioSciences
DTIL
$181M
$211K 0.09%
1,165
-170
-13% -$44.5K
TCDA
275
DELISTED
Tricida, Inc. Common Stock
TCDA
$200K 0.08%
9,104
-1,340
-13% -$43K
9 10
11
12 13

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM

Virtus ETF Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, Virtus ETF Advisers held 504 positions worth $243M, down 60% from $612M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Virtus ETF Advisers withdrew a net $216M in Q1 2020, closing 94 positions and reducing 307 holdings. Its most notable exit was Reliance Steel & Aluminium, an estimated $4.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Virtus ETF Advisers opened a new position in Newmont worth $1.82M.

  • Virtus ETF Advisers's largest Q1 2020 buy was Newmont: 40,138 shares worth $1.82M.
  • Virtus ETF Advisers added most to Oxford Square Capital in Q1 2020, an estimated $1.88M increase.
  • Virtus ETF Advisers's biggest Q1 2020 reduction was Air Products & Chemicals, cutting an estimated $3.72M.
  • Virtus ETF Advisers fully exited Reliance Steel & Aluminium in Q1 2020, selling an estimated $4.3M.
  • Virtus ETF Advisers's ten largest holdings make up 9.9% of its $243M portfolio in Q1 2020.
  • Virtus ETF Advisers opened 52 new positions and closed 94 in Q1 2020.
  • Virtus ETF Advisers's portfolio value fell 60% quarter-over-quarter to $243M.

Based on Virtus ETF Advisers's 13F filing for Q1 2020, filed 14 May 2020.